MJNA News 12/26/2016 - 0.1475
Post# of 273249
Posted On: 12/26/2016 6:29:26 AM
Medical Marijuana, Inc. $MJNA News
Last updated 12/26/2016 - 0.1475
Medical Marijuana, Inc. Releases In-Depth Video Series Featuring New Executive Team and Lives Strengthened by Company's Products
Dec 22, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Releases In-Depth Video Series Featuring New Executive Team and Lives Strengthened by Company's Products
Company Provides Real-Life Testimony Displaying Its Origins, Unprecedented Firsts and Major Accomplishments in 2016
SAN DIEGO, CA--(Marketwired - December 22, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced the release of an in-depth video series showcasing the Company's history and unprecedented accomplishments as a "Company of Firsts." From establishing the nation's first cannabidiol (CBD) oil pipeline from Europe to the U.S. to creating a standard for lab testing of cannabis products, the video series highlights the many ground-breaking achievements of Medical Marijuana, Inc. and what the future holds.
As part of an outreach campaign, the company has decided to highlight various individuals that have been affected by the company's now ever-expanding presence around the globe. The video marks a milestone in the company's consistent rise as one of the foremost leaders in the medical cannabis and hemp industry.
The series can be accessed for viewing on www.medicalmarijuanainc.com. In addition to personal stories of success, the video brings viewers on a journey that follows the rise of the company, from its beginnings as a startup to its standing as one of the leading innovators in the cannabis and hemp industry.
"In the case of our new video series, seeing really is believing," said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. "We are honored to bring our story of hope to the world. It is one thing to hear about the transformative effects of our products, or to read about it in research studies. But starting today, you can now see the real-life impact our products offer to countless lives around the world."
Dr. Titus added, "There are many who suffer in silence and whose calls for help go unanswered. However, because of the strides made by our company, I am pleased to say that we are beginning to answer those calls. This video is our chance to tell the world that we hear your pain. I am confident that with our continued strides in the cannabis and hemp industry, we will make the world a better place."
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Begins Importation of Real Scientific Hemp Oil-X(TM) Product Line Into Brazil
Dec 21, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Begins Importation of Real Scientific Hemp Oil-X(TM) Product Line Into Brazil
Consumers Looking for Zero THC Version of Real Scientific Hemp Oil (RSHO(TM)) Products Now Have Solution From First-Ever Approved Company
SAN DIEGO, CA--(Marketwired - December 21, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Real Scientific Hemp Oil-X™ (RSHO-X™) product line is now being imported into Brazil through the company's subsidiary, HempMeds Brasil™.
The RSHO-X™ product line was developed as the first tetrahydrocannabinol (THC)-free hemp oil product on the market. Originally developed to fit Mexico's strict import regulations, RSHO-X™ was the first cannabis product ever legally imported into Mexico.
Recently, Dr Carlos Aguirre performed an informational study in Mexico where he used RSHO-X™ on various patients and children suffering from Epilepsy. Dr. Aguirre saw an average seizure reduction of 67% within his patient population, all with no adverse side effects. The results from this study will soon be published in Neurology Research International, an open access, peer-reviewed open access journal that publishes original research articles, review articles and clinical studies in all areas of neurology.
This RSHO-X product would be the first cannabis based product to actually qualify for World Anti-Doping standards, so that professional sport, Olympic athletes can take without fear of failing a drug screening.
"Our company was honored to create and distribute the first cannabis product to be approved for import and use in Brazil through medical prescription -- we are excited to offer this important new hemp oil product line to the customers there," said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. "In line with our mission to bring cannabinoid access to all, RSHO-X™ opens up a growing market of customers looking to avoid THC but still experience the similar benefits awarded those who enjoy our traditional CBD hemp oil products."
"HempMeds Brasil™ has been instrumental in creating access to medical cannabis in Brazil and we will continue to educate the medical community and regulatory agencies to make the process for obtaining cannabis products like RSHO-X™ easier," added Dr. Titus.
RSHO-X™ is the preferred hemp oil supplement for those looking to completely avoid even trace amounts of THC and fits the requirements of anyone liable to drug tests. These RSHO-X™ users could range from:
First responders such as firefighters and police officers that deal with physical exertion and stress and must fit their employer's restrictions on cannabis use.
Veterans and active military personal who have restrictions from Veterans Affairs policies, despite several studies conducted on the potential benefits of cannabis for veterans suffering with PTSD.
Competing athletes who face restrictive cannabis testing policies for the sports' governing bodies. RSHO-X™ in the first cannabidiol (CBD) hemp oil product able to pass the restriction on cannabis set forth by the World Anti-Doping Agency, enabling athletes to enjoy the benefits of CBD without fear of negative consequences.
Parents looking to supplement their child with CBD hemp oil but wish to avoid exposing them to even trace amounts of THC, allowing them to benefit the balancing effects cannabinoids have on the human body.
About HempMeds Brasil™
HempMeds Brasil™ currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson's and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds Brasil™ is working on additional approvals for multiple indications.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The following files are available for download:
logo 1
RSHO-X-Table
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Welcomes Caroline Heinz to Executive Team
Dec 20, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Welcomes Caroline Heinz to Executive Team
Ms. Heinz Joins HempMeds Brasil(TM) Team as New Director of Operations for Brazil-Based Company
SAN DIEGO, CA--(Marketwired - December 20, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Caroline Heinz has been appointed as the new Director of Operations for their subsidiary, HempMeds Brasil™.
Heinz has played a vital role as part of the HempMeds Brasil™ team since its launch in 2014, working on brand development and marketing. Previous to her involvement with HempMeds Brasil™, Heinz worked in numerous high-level positions in various Brazilian and U.S. organizations such as world renowned media outlet TV Globo.
Ms. Heinz earned her Masters of Business Administration degree from San Diego University for Integrative Studies, and holds a Bachelor's degree in Social Communications from UNIVERCIDADE, in Rio de Janeiro, Brazil, majoring in Journalism.
"Ms. Heinz has been an integral part of the HempMeds Brasil™ team for many years now and we are very glad to announce her promotion Director of Operations for the company, a division of Medical Marijuana, Inc. (OTC PINK: MJNA)," said Chief Executive Officer, Dr. Stuart Titus. "When Real Scientific Hemp Oil™ (RSHO™) became the first medical cannabis product to be approved for import and use in Brazil, we knew that this was a huge opportunity and very important market for our company to be part of. We believe that Ms. Heinz has the talent to continue the upward momentum that HempMeds has in this emerging cannabinoid market within Brazil."
With the approval of RSHO™, Brazil also became the first Latin American country to approve prescriptions for any medical cannabis product, with Mexico and Paraguay following suit - issuing the first-ever approvals for Medical Marijuana, Inc. products in both countries.
"HempMeds Brasil™ has been instrumental in creating access to medical cannabis in Brazil, were we work with thousands of families in need of help gaining legal access to RSHO™," Heinz said. "I am beyond excited about taking on this new responsibility for a company that I fully believe in, which is working hard to educate the medical community and regulatory agencies to make the process for obtaining cannabis products like RSHO™ easier."
About HempMeds Brasil™
HempMeds Brasil™ currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson's and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds Brasil™ is working on additional approvals for multiple indications.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc., una subsidiaria de HempMeds(R), anuncia la creación de operaciones comerciales en Chile e inicia la importación a Argentina
Dec 15, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc., una subsidiaria de HempMeds(R), anuncia la creación de operaciones comerciales en Chile e inicia la importación a Argentina
La empresa continúa sus iniciativas de expansión internacional con la formación de una empresa en Chile e inicia la importación de Real Scientific Hemp Oil(TM) al mercado argentino
SAN DIEGO, CA--(Marketwired - 15 de diciembre de 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), la primera empresa de cannabis que cotiza en bolsa en los Estados Unidos, anunció hoy que su subsidiaria HempMeds® ha constituido una nueva empresa en Chile. Además, como parte de su iniciativa de expansión al mercado latinoamericano, la empresa ya ha comenzado a importar a Argentina su principal producto Real Scientific Hemp Oil™ (RSHO™).
Esta nueva expansión latinoamericana se produce después de que la empresa recibiera la primera aprobación federal de la COFEPRIS para importar un producto de cannabis a México, junto con las otras dos primeras aprobaciones históricas para importar RSHO™ a Brasil y Paraguay.
"Estamos orgullosos de estar construyendo una empresa en Chile y expandiendo nuestra distribución de HempMeds®RSHO™ a más países de Latinoamérica". Otros países de la región, como es el caso de Brasil, Paraguay y México, han legalizado los productos CBD para el tratamiento de varias indicaciones médicas, de manera que desarrollar una presencia empresarial en Chile y una red de distribución en Argentina parecía la mejor dirección lógica", dijo el CEO de Medical Marijuana, Inc., el Dr. Stuart Titus. "Estamos entusiasmados con el nuevo emprendimiento y esperamos ayudar a desarrollar nuevas oportunidades económicas para la gente de Chile y Argentina".
"La nueva legislación, como la reciente decisión de Argentina de permitir la importación del aceite de cannabis representa un paso gigantesco de nuestro objetivo continuo de educar al mundo sobre las potenciales ventajas médicas que pueden proporcionar los cannabinoides". Creemos que Chile será uno de nuestros mercados más grandes en América Latina debido a estas nuevas regulaciones y al plan del gobierno para sufragar los productos para los ciudadanos en el futuro", agregó el Dr. Titus.
En Chile, ha habido muchas novedades desde la aprobación de una medida que legaliza el cultivo y la venta de marihuana con fines medicinales en 2015 que proporcionó marihuana medicinal gratuita a casi 4.000 pacientes. A principios de este año, el país inauguró la mayor granja de marihuana medicinal en América Latina. Además, la presidenta de Chile, Michelle Bachelet firmó un decreto para eliminar la marihuana de una lista de drogas peligrosas. El decreto también permite que la marihuana medicinal se venda en las farmacias, ofreciéndoles un mayor acceso a los pacientes.
Acerca de HempMeds ®
HempMeds® que creó el primer "canal de suministro de CBD" en los Estados Unidos, es una compañía de la cartera de empresas de Medical Marijuana, Inc. (OTC PINK: MJNA) y el principal distribuidor exclusivo y compañía de marketing por contrato de la Compañía. HempMeds ofrece legalmente al mercado estadounidense una amplia gama de productos de cannabis y CBD en los 50 estados.
Acerca de Medical Marijuana, Inc.
Nuestra misión es convertirnos en los principales innovadores en la industria de cannabis y cáñamo, aprovechando nuestro equipo de profesionales para buscar, evaluar y adquirir compañías y productos de valor agregado, a la vez que les permitimos mantener su integridad y su espíritu emprendedor. Nos esforzamos por crear conciencia dentro de nuestra industria, desarrollar negocios ecológicos y económicamente sostenibles y, a su vez, aumentar el valor para los accionistas. Para obtener más información acerca de la cartera y las compañías de inversión de Medical Marijuana, Inc., ingrese en www.medicalmarijuanainc.com.
Para ver la declaración en video de Medical Marijuana, Inc., haga clic aquí. Se recomienda a los accionistas que visiten también Medical Marijuana, Inc. Shop en cuanto a productos con descuento.
DESCARGO DE RESPONSABILIDAD SOBRE DECLARACIONES PROSPECTIVAS
Este comunicado de prensa puede contener ciertas declaraciones e información de carácter prospectivo, tal como se define en la sección 27A de la Ley de Valores de 1933 y la sección 21E de la Ley de Bolsas de Valores de 1934 y está sujeto a las disposiciones de puerto seguro establecidas por dichas secciones. Este material contiene declaraciones acerca de futuros eventos o resultados financieros esperados que son de naturaleza prospectiva y están sujetos a riesgos e incertidumbres. Tales declaraciones prospectivas por definición conllevan riesgos, incertidumbres y otros factores que pueden causar que los resultados reales, el rendimiento o los logros de Medical Marijuana, Inc. sean sustancialmente diferentes a las declaraciones emitidas en este comunicado.
DECLARACIÓN DE LA ADMINISTRACIÓN DE DROGAS Y ALIMENTOS (FDA)
Estas declaraciones no han sido evaluadas por la FDA y no tienen el propósito de diagnosticar, tratar ni curar ningún tipo de enfermedad.
DIVULGACIÓN LEGAL
Medical Marijuana Inc. no vende ni distribuye ningún producto que infrinja la Ley de Sustancias Controladas de los Estados Unidos (US.CSA). Estas compañías producen, venden y distribuyen productos con aceite de cáñamo y participan en la distribución legal a nivel federal de productos medicinales que contienen marihuana dentro de determinados mercados internacionales. El cannabidiol es un ingrediente natural del aceite de cáñamo.
Información de contacto
Contacto de Relaciones Públicas:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Contacto de Negocios Corporativos:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
Símbolo OTC: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Contacto de Relaciones con Inversores:
EquiNet, LLC
Línea gratuita: (877) 964.6463
Oficina/Directo: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc., subsidiária da HempMeds(R) anuncia criação de empresa no Chile, início de importação para a Argentina
Dec 15, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc., subsidiária da HempMeds(R) anuncia criação de empresa no Chile, início de importação para a Argentina
Empresa dá continuidade a suas iniciativas de expansão internacional com criação de empresa no Chile e início de importação do Real Scientific Hemp Oil(TM) para a Argentina
SAN DIEGO, CA--(Marketwired - 15 de dezembro de 2016) - A Medical Marijuana, Inc. (OTC PINK: MJNA), primeira empresa de cannabis comercializada publicamente nos Estados Unidos, anunciou hoje que a sua subsidiária HempMeds® criou uma nova empresa no Chile. Além disso, como parte da sua iniciativa de expansão no mercado da América Latina, a empresa deu início à importação do seu principal produto, Real Scientific Hemp Oil™ (RSHO™) para a Argentina.
Esta nova expansão para a América Latina dá seguimento à primeira aprovação federal do COFEPRIS para a importação de produto de cannabis no México, juntamente com duas outras aprovações históricas para a importação do RSHO™ para o Brasil e Paraguai.
"Estamos orgulhosos com a criação da nossa empresa no Chile e com a expansão da distribuição do HempMeds®RSHO™ para mais países na América Latina. Outros países da região, tais como Brasil, Paraguai e México, legalizaram os produtos CBD para tratamento de vários problemas médicos, por isso uma empresa no Chile e uma rede de distribuição para a Argentina foi o melhor direcionamento lógico para a empresa", disse o CEO da Medical Marijuana, Inc., Dr. Stuart Titus. "Estamos muito contentes com o novo empreendimento e esperamos poder ajudar na criação de novas oportunidades econômicas para as pessoas do Chile e da Argentina".
"Novas legislações, tal como a decisão da Argentina de autorizar a importação do óleo de cannabis, são um passo gigantesco em direção da nossa meta contínua de educar o mundo sobre as vantagens médicas em potencial que os canabióides podem proporcionar. O Chile será um dos nossos maiores mercados na América Latina devido a esses novos regulamentos e o plano do governo de pagar pelos produtos para a população no futuro", acrescentou o Dr. Titus.
O Chile teve muito avanço desde a aprovação de uma lei que legaliza o cultivo e a venda de marijuana para fins medicinais em 2015, que proporciona a quase 4.000 pacientes marijuana medicinal gratuitamente. No início do ano, o país inaugurou sua maior fazenda de marijuana medicinal da América Latina. A presidente do Chile, Michelle Bachelet assinou uma lei para a remoção da marijuana da lista de drogas perigosas. A medida também permite que a marijuana médica seja vendida nas farmácias, dando aos pacientes maior acesso.
HempMeds ®
A HempMeds®, que criou o primeiríssimo "pipeline de CBD" nos Estados Unidos, é uma empresa de portfólio corporativo da Medical Marijuana, Inc. (OTC PINK: MJNA), e é a distribuidora exclusiva da Empresa e empresa de marketing contratada. A HempMeds oferece uma ampla variedade de produtos de cannabis e de CBD legalmente nos 50 estados dos Estados Unidos.
Medical Marijuana Inc.
Temos por missão ser o principal inovador do mercado de cannabis e hemp, utilizando nossos profissionais para obter, avaliar e comprar empresas e produtos de valor agregado, mantendo sua integridade e espírito empresarial. Buscamos disseminar o conhecimento na nossa indústria, desenvolver empresas ambientalmente positivas e economicamente sustentáveis, e aumentar o valor dos acionistas. Para mais detalhes sobre as empresas do portfólio e de investimentos da Medical Marijuana, Inc., visite www.medicalmarijuanainc.com.
Para ver o vídeo com a declaração da Medical Marijuana, Inc., clique aqui. Os acionistas também devem visitar o site Medical Marijuana, Inc. Shop para ver a lista de produtos oferecidos com desconto.
DECLARAÇÕES DE PREVISÃO
Este press release pode conter certas declarações e informações de previsão, de acordo com o disposto na Seção 27A do Securities Act of 1933 e Seção 21E do Securities Exchange Act of 1934, sujeitas ao regulamento de Safe Harbor estabelecido por tais seções. Este material contém declarações sobre eventos e/ou resultados futuros esperados que são consideradas declarações de previsão sujeitas a riscos e incertezas. Tais declarações de previsão, por definição, envolvem riscos, incertezas e outros fatores, que podem fazer com que os resultados, desempenho ou conquistas reais da Medical Marijuana, Inc. sejam substancialmente diferentes dos resultados previstos.
DECLARAÇÃO DA FOOD AND DRUG ADMINISTRATION (FDA) DOS EUA
Estas declarações não foram analisadas pela FDA e não têm por objetivo diagnosticar, tratar ou curar nenhuma doença.
DECLARAÇÃO LEGAL
A Medical Marijuana Inc. não vende nem distribui nenhum produto que violem a lei United States Controlled Substances Act (US.CSA). Estas empresas cultivam, vendem e distribuem produtos de hemp e estão envolvidas na distribuir legal de produtos medicinais de marijuana para certos mercados internacionais. Cannabidiol é um ingrediente natural do hemp oil.
Informação de Contato
Contato de Relações Públicas:
Andrew Hard
CEO
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Contato Comercial:
Nicholas R. Massalas
Diretor de Desenvolvimento Comercial
Medical Marijuana, Inc.
Símbolo OTC: MJNA
Ligação Gratuita: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Contato de Relação com o Investidor:
EquiNet, LLC
Ligação Gratuita: (877) 964.6463
Escritório/Direto: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Subsidiary HempMeds(R) Announces Formation of Business Operations in Chile, Begins Importation Into Argentina
Dec 15, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Subsidiary HempMeds(R) Announces Formation of Business Operations in Chile, Begins Importation Into Argentina
Company Continues International Expansion Initiatives with Company Formation in Chile and Begins Importing Real Scientific Hemp Oil(TM) to Argentinian Market
SAN DIEGO, CA--(Marketwired - December 15, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary company HempMeds® has formed a new business in Chile. Additionally, as part of the company's Latin American market expansion initiative, the company has begun importing their flagship product Real Scientific Hemp Oil™ (RSHO™) to Argentina.
This new Latin American expansion comes after the company received the first-ever federal approval from COFEPRIS to import a cannabis product into Mexico, along with two other historic first-ever approvals to import RSHO™ into Brazil and Paraguay.
"We are proud to be building a business in Chile and expanding our distribution of HempMeds® RSHO™ into more countries in Latin America. Other countries in the region such as Brazil, Paraguay and Mexico have legalized CBD products for the treatment of multiple medical indications, so developing a business presence in Chile and a distribution network into Argentina seemed like the best logical direction," said Chief Executive Officer of Medical Marijuana, Inc., Dr. Stuart Titus. "We are excited about the new venture and look forward to helping develop new economic opportunities for the people of Chile and Argentina."
"New legislation, like the recent decision by Argentina to allow the importation of cannabis oil are a giant step in our ever-continuing goal of educating the world on the potential medical advantages cannabinoids can provide. We believe Chile will be one of our largest markets in Latin America due to these new regulations and the government's plan to pay for the products for citizens in the future" added Dr. Titus.
In Chile, there have been many developments since the approval of a measure legalizing the cultivation and sale of marijuana for medicinal purposes in 2015 that have provided nearly 4,000 patients with free medical marijuana. Earlier this year the country opened the largest medicinal marijuana farm in Latin America. Also, Chilean President Michelle Bachelet signed a measure to remove marijuana from a list of dangerous drugs. The measure also allows for medical marijuana to be sold in pharmacies, giving patients greater access.
About HempMeds®
HempMeds® which created the first-ever "CBD pipeline" into the United States, is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company's exclusive master distributor and contracted marketing company. HempMeds offers the US market a wide range of cannabis and CBD products legally across all 50 states.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Announces Excitement for Recent Mexico Cannabis Regulations Vote
Dec 14, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Announces Excitement for Recent Mexico Cannabis Regulations Vote
New Ruling Helps Move Mexico Closer to Cannabis Legalization in the Country
SAN DIEGO, CA--(Marketwired - December 14, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it commends the Mexican senate for voting in favor of extending regulations for certain cannabis products. With the new regulations, more people in need of cannabis and cannabidiol (CBD) for medical care will have more access to products, including our RSHO brand of products.
Medical Marijuana, Inc. subsidiary HempMeds® Mexico`s non-psychoactive, THC-free hemp-based CBD product Real Scientific Hemp Oil-X™ (RSHO-X™) was the first-ever federally approved CBD product in Mexico. Now with the new regulations, it's a goal for HempMeds® Mexico to bring all their RSHO products into the country to help more customers and provide options.
"These new regulations in Mexico will be a major step forward for the country once they pass the Mexico House of Representatives then signed fully into law. This will also represent a major accomplishment for the cannabis industry as a whole. We are very happy with the outcome and trend that the Mexican Senate put forward with this vote," stated Chief Executive Officer of Medical Marijuana, Inc., Dr. Stuart Titus. "Our Company has always supported access to all cannabinoids, as we recognize the potential medical advantages they can provide.
"We believe this new legislation in Mexico will increase access to additional cannabis-based products and we will continue encouraging further cannabis reforms by educating doctors and lawmakers on the benefits of cannabinoids -- then creating products that can safely and reliably provide our customers with the cannabinoids they seek," added Dr. Titus.
The new law approves the use of marijuana with therapeutic and medicinal use, with the reforms through General Health Law. This law will allow the access to cannabis based products to treat chronic and degenerative diseases. This law is yet to be approved by the House of Representative, which may be next year.
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at: http://www.hempmeds.mx.
About HempMeds®
HempMeds® which created the first-ever "CBD pipeline" into the United States, is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company's exclusive master distributor and contracted marketing company. HempMeds offers the US market a wide range of cannabis and CBD products legally across all 50 states.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana (MJNA) Capitalizes on the $450 Million CBD Market -- CFN Media
Dec 14, 2016
OTC Disclosure & News Service
-
Medical Marijuana (MJNA) Capitalizes on the $450 Million CBD Market -- CFN Media
SEATTLE, WA--(Marketwired - Dec 14, 2016) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.'s (OTC PINK: MJNA) global position in the burgeoning market for hemp-derived, cannabidiol (CBD)-based products.
According to the Hemp Industry Association, annual retail sales of hemp products grew at a 10.4% clip to surpass $570 million in 2015. Industrial applications still account for most of the market, but hemp foods, personal care products, supplements, and hemp-derived CBD products have experienced a growing market share. Hemp Business Journal's CBD Report projects that hemp-based CBD products will become a $450 million market by 2020.
Google Scholar has archived more than 2,000 research papers discussing CBD's role in the treatment of various medical conditions this year. With hemp-based CBDs widely available to researchers in the United States, a growing number of researchers have become interested in the cannabinoid's potential across a spectrum of diseases. These published papers could eventually sway the medical community and open the door to new therapeutics.
Medical Marijuana Inc. is building a global footprint in the CBD industry with its Real Scientific Hemp Oil ("RSHO"
- a hemp-derived pure CBD oil that's available over the counter - until the scientific community catches up. With distribution across all of the United States and numerous countries around the world including Mexico, Columbia, and Brazil, the company has become a leader in providing pure CBD oils that have been shown to be effective in treating epilepsy, pain, and other conditions.
In addition to its over-the-counter products, the company has a 45.5% stake in AXIM Biotech Inc., which owns the patent for chewing gum as a delivery method for cannabinoids. The company will soon start Phase III clinical trials for their combination CBD/THC gum MedChew™ RX for the treatment of spasticity associated with multiple sclerosis and, once approved by the EMA, the gum will be offered across the European Union.
The company also holds a portfolio of other companies focused on distributing and marketing CBDs and advancing the science of cannabinoids. For example, its Kannaway subsidiary is focused on marketing cannabinoids throughout the United States with a variety of different products targeting areas like skincare, while its Kannalife subsidiary holds an exclusive license from the NIH for the commercialization of US Patent 6,630,507 for neuroprotection.
Follow the link to read the full article: http://www.cannabisfn.com/medical-marijuana-m...bd-market/
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id...1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit http://www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Forbes Features Medical Marijuana, Inc. in Article Citing Company's Sales Data After Starting CBD Market `That Could Grow 700% by 2020'
Dec 13, 2016
OTC Disclosure & News Service
-
Forbes Features Medical Marijuana, Inc. in Article Citing Company's Sales Data After Starting CBD Market `That Could Grow 700% by 2020'
Article Features Positive Growth Stats for the CBD Market and Information on Medical Marijuana, Inc. Products, Investments and Subsidiary Companies
SAN DIEGO, CA--(Marketwired - December 13, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its products and investments were featured in a Forbes article focused on the current cannabidiol (CBD) market size and anticipated massive growth.
The Dec. 12, 2016, article entitled "The Cannabis Market That Could Grow 700% by 2020" states, "The Hemp Business Journal estimated that the CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources." Those figures cited would total a 700% increase from 2016.
The article continues: "Medical Marijuana, Inc. said that there were $65 million in hemp-based CBD sales in 2015 and that they are the current market leader with over $800,000 in retail CBD sales per month. Their CBD sales have grown from $3.4 [million] in 2013 and are expected to be $9 million in 2016."
"When Medical Marijuana, Inc. launched the first-ever hemp-based CBD products, the Company knew that we were creating an intriguing product category that could potentially help millions of people to higher levels of overall health and wellness. We're grateful to Forbes for covering our industry," said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. "However, not everyone predicted a $65 million industry within two years and a projected $450 million industry within seven years. That has meant jobs and livelihood for thousands of people around the world."
"Further, the black market for cannabis (THC) products has been developing for the past 50 years and today reaches $120 billion in the US and $240 billion worldwide. We continue to believe that when similarly developed, the CBD marketplace will approach 50% of these figures, so $60 billion in the US and $120 billion worldwide."
The Forbes article also discusses many of Medical Marijuana, Inc.'s subsidiary companies including Kannaway and their line of Revive products like Revive Pro-X, a hemp oil supplement containing no tetrahydrocannabinol (THC), that is made for customers like athletes who need to avoid products with THC.
Further, the article also discussed Medical Marijuana, Inc. investment AXIM® Biotechnologies, Inc. (OTC: AXIM) and the patent received by the company for the CBD chewing gum CanChew®. Medical Marijuana, Inc. owns 47% of Axim stock.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About AXIM®
AXIM® Biotechnologies, Inc. (OTC: AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. We prioritize the well-being of our customers while embracing a solid fiscal strategy. Medical Marijuana, Inc. is a major investor in AXIM. For more information, visit www.AXIMBiotech.com.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc.'s HempMeds(R) to Showcase Award-Winning Hemp Oil Cannabidiol (CBD) and Cannabis Beauty Defined Products at A4M World Congress
Dec 08, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc.'s HempMeds(R) to Showcase Award-Winning Hemp Oil Cannabidiol (CBD) and Cannabis Beauty Defined Products at A4M World Congress
HempMeds(R) to Educate Thousands of Global Healthcare Professionals Attending the World Congress on Anti-Aging Medicine on Rapidly Emerging Hemp Cannabidiol (CBD) Industry
SAN DIEGO, CA--(Marketwired - December 08, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® is exhibiting at the 24th annual American Academy of Anti-Aging Medicine World Congress (A4M), with the Company's extensive portfolio of retail-ready cannabis products featured at the Venetian/Palazzo Hotel in Las Vegas from Dec. 9-11.
HempMeds® representatives will exhibit at booth #1027 the Company's groundbreaking Real Scientific Hemp Oil™ (RSHO™) including its hemp cannabidiol (CBD) oil raw ingredient and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™), the first-ever cannabis product to receive approval from the federal government of Mexico for importation. Additionally, the Company will be showcasing their award-winning range of Cannabis Beauty Defined™ products that are a unique mixture of CBD hemp oil and a specially formulated mixture of herbs to help protect and nourish the skin.
"We are very fortunate to have the opportunity to attend another A4M Conference and to be able to bring our products to the forefront of this market," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We are proud that our products will be showcased to thousands of the premier anti-aging doctors and experts from around the world. The Company's goal is to educate and open up a worldwide conversation on CBD from the hemp plant."
The A4M Conference is dedicated to the advancement of technology to detect, prevent, and treat aging-related disease and to promote research into methods to optimize the human aging process. Patent No. 6630507, awarded to the U.S. Department of Health and Human Services, states that cannabinoids have been found to have antioxidant and anti-aging properties.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
Image Available: http://www.marketwire.com/library/MwGo/2016/1...9b117e.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/1...c6332a.jpg
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Last updated 12/26/2016 - 0.1475
Medical Marijuana, Inc. Releases In-Depth Video Series Featuring New Executive Team and Lives Strengthened by Company's Products
Dec 22, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Releases In-Depth Video Series Featuring New Executive Team and Lives Strengthened by Company's Products
Company Provides Real-Life Testimony Displaying Its Origins, Unprecedented Firsts and Major Accomplishments in 2016
SAN DIEGO, CA--(Marketwired - December 22, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced the release of an in-depth video series showcasing the Company's history and unprecedented accomplishments as a "Company of Firsts." From establishing the nation's first cannabidiol (CBD) oil pipeline from Europe to the U.S. to creating a standard for lab testing of cannabis products, the video series highlights the many ground-breaking achievements of Medical Marijuana, Inc. and what the future holds.
As part of an outreach campaign, the company has decided to highlight various individuals that have been affected by the company's now ever-expanding presence around the globe. The video marks a milestone in the company's consistent rise as one of the foremost leaders in the medical cannabis and hemp industry.
The series can be accessed for viewing on www.medicalmarijuanainc.com. In addition to personal stories of success, the video brings viewers on a journey that follows the rise of the company, from its beginnings as a startup to its standing as one of the leading innovators in the cannabis and hemp industry.
"In the case of our new video series, seeing really is believing," said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. "We are honored to bring our story of hope to the world. It is one thing to hear about the transformative effects of our products, or to read about it in research studies. But starting today, you can now see the real-life impact our products offer to countless lives around the world."
Dr. Titus added, "There are many who suffer in silence and whose calls for help go unanswered. However, because of the strides made by our company, I am pleased to say that we are beginning to answer those calls. This video is our chance to tell the world that we hear your pain. I am confident that with our continued strides in the cannabis and hemp industry, we will make the world a better place."
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Begins Importation of Real Scientific Hemp Oil-X(TM) Product Line Into Brazil
Dec 21, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Begins Importation of Real Scientific Hemp Oil-X(TM) Product Line Into Brazil
Consumers Looking for Zero THC Version of Real Scientific Hemp Oil (RSHO(TM)) Products Now Have Solution From First-Ever Approved Company
SAN DIEGO, CA--(Marketwired - December 21, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Real Scientific Hemp Oil-X™ (RSHO-X™) product line is now being imported into Brazil through the company's subsidiary, HempMeds Brasil™.
The RSHO-X™ product line was developed as the first tetrahydrocannabinol (THC)-free hemp oil product on the market. Originally developed to fit Mexico's strict import regulations, RSHO-X™ was the first cannabis product ever legally imported into Mexico.
Recently, Dr Carlos Aguirre performed an informational study in Mexico where he used RSHO-X™ on various patients and children suffering from Epilepsy. Dr. Aguirre saw an average seizure reduction of 67% within his patient population, all with no adverse side effects. The results from this study will soon be published in Neurology Research International, an open access, peer-reviewed open access journal that publishes original research articles, review articles and clinical studies in all areas of neurology.
This RSHO-X product would be the first cannabis based product to actually qualify for World Anti-Doping standards, so that professional sport, Olympic athletes can take without fear of failing a drug screening.
"Our company was honored to create and distribute the first cannabis product to be approved for import and use in Brazil through medical prescription -- we are excited to offer this important new hemp oil product line to the customers there," said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. "In line with our mission to bring cannabinoid access to all, RSHO-X™ opens up a growing market of customers looking to avoid THC but still experience the similar benefits awarded those who enjoy our traditional CBD hemp oil products."
"HempMeds Brasil™ has been instrumental in creating access to medical cannabis in Brazil and we will continue to educate the medical community and regulatory agencies to make the process for obtaining cannabis products like RSHO-X™ easier," added Dr. Titus.
RSHO-X™ is the preferred hemp oil supplement for those looking to completely avoid even trace amounts of THC and fits the requirements of anyone liable to drug tests. These RSHO-X™ users could range from:
First responders such as firefighters and police officers that deal with physical exertion and stress and must fit their employer's restrictions on cannabis use.
Veterans and active military personal who have restrictions from Veterans Affairs policies, despite several studies conducted on the potential benefits of cannabis for veterans suffering with PTSD.
Competing athletes who face restrictive cannabis testing policies for the sports' governing bodies. RSHO-X™ in the first cannabidiol (CBD) hemp oil product able to pass the restriction on cannabis set forth by the World Anti-Doping Agency, enabling athletes to enjoy the benefits of CBD without fear of negative consequences.
Parents looking to supplement their child with CBD hemp oil but wish to avoid exposing them to even trace amounts of THC, allowing them to benefit the balancing effects cannabinoids have on the human body.
About HempMeds Brasil™
HempMeds Brasil™ currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson's and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds Brasil™ is working on additional approvals for multiple indications.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The following files are available for download:
logo 1
RSHO-X-Table
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Welcomes Caroline Heinz to Executive Team
Dec 20, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Subsidiary HempMeds Brasil(TM) Welcomes Caroline Heinz to Executive Team
Ms. Heinz Joins HempMeds Brasil(TM) Team as New Director of Operations for Brazil-Based Company
SAN DIEGO, CA--(Marketwired - December 20, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Caroline Heinz has been appointed as the new Director of Operations for their subsidiary, HempMeds Brasil™.
Heinz has played a vital role as part of the HempMeds Brasil™ team since its launch in 2014, working on brand development and marketing. Previous to her involvement with HempMeds Brasil™, Heinz worked in numerous high-level positions in various Brazilian and U.S. organizations such as world renowned media outlet TV Globo.
Ms. Heinz earned her Masters of Business Administration degree from San Diego University for Integrative Studies, and holds a Bachelor's degree in Social Communications from UNIVERCIDADE, in Rio de Janeiro, Brazil, majoring in Journalism.
"Ms. Heinz has been an integral part of the HempMeds Brasil™ team for many years now and we are very glad to announce her promotion Director of Operations for the company, a division of Medical Marijuana, Inc. (OTC PINK: MJNA)," said Chief Executive Officer, Dr. Stuart Titus. "When Real Scientific Hemp Oil™ (RSHO™) became the first medical cannabis product to be approved for import and use in Brazil, we knew that this was a huge opportunity and very important market for our company to be part of. We believe that Ms. Heinz has the talent to continue the upward momentum that HempMeds has in this emerging cannabinoid market within Brazil."
With the approval of RSHO™, Brazil also became the first Latin American country to approve prescriptions for any medical cannabis product, with Mexico and Paraguay following suit - issuing the first-ever approvals for Medical Marijuana, Inc. products in both countries.
"HempMeds Brasil™ has been instrumental in creating access to medical cannabis in Brazil, were we work with thousands of families in need of help gaining legal access to RSHO™," Heinz said. "I am beyond excited about taking on this new responsibility for a company that I fully believe in, which is working hard to educate the medical community and regulatory agencies to make the process for obtaining cannabis products like RSHO™ easier."
About HempMeds Brasil™
HempMeds Brasil™ currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson's and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds Brasil™ is working on additional approvals for multiple indications.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc., una subsidiaria de HempMeds(R), anuncia la creación de operaciones comerciales en Chile e inicia la importación a Argentina
Dec 15, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc., una subsidiaria de HempMeds(R), anuncia la creación de operaciones comerciales en Chile e inicia la importación a Argentina
La empresa continúa sus iniciativas de expansión internacional con la formación de una empresa en Chile e inicia la importación de Real Scientific Hemp Oil(TM) al mercado argentino
SAN DIEGO, CA--(Marketwired - 15 de diciembre de 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), la primera empresa de cannabis que cotiza en bolsa en los Estados Unidos, anunció hoy que su subsidiaria HempMeds® ha constituido una nueva empresa en Chile. Además, como parte de su iniciativa de expansión al mercado latinoamericano, la empresa ya ha comenzado a importar a Argentina su principal producto Real Scientific Hemp Oil™ (RSHO™).
Esta nueva expansión latinoamericana se produce después de que la empresa recibiera la primera aprobación federal de la COFEPRIS para importar un producto de cannabis a México, junto con las otras dos primeras aprobaciones históricas para importar RSHO™ a Brasil y Paraguay.
"Estamos orgullosos de estar construyendo una empresa en Chile y expandiendo nuestra distribución de HempMeds®RSHO™ a más países de Latinoamérica". Otros países de la región, como es el caso de Brasil, Paraguay y México, han legalizado los productos CBD para el tratamiento de varias indicaciones médicas, de manera que desarrollar una presencia empresarial en Chile y una red de distribución en Argentina parecía la mejor dirección lógica", dijo el CEO de Medical Marijuana, Inc., el Dr. Stuart Titus. "Estamos entusiasmados con el nuevo emprendimiento y esperamos ayudar a desarrollar nuevas oportunidades económicas para la gente de Chile y Argentina".
"La nueva legislación, como la reciente decisión de Argentina de permitir la importación del aceite de cannabis representa un paso gigantesco de nuestro objetivo continuo de educar al mundo sobre las potenciales ventajas médicas que pueden proporcionar los cannabinoides". Creemos que Chile será uno de nuestros mercados más grandes en América Latina debido a estas nuevas regulaciones y al plan del gobierno para sufragar los productos para los ciudadanos en el futuro", agregó el Dr. Titus.
En Chile, ha habido muchas novedades desde la aprobación de una medida que legaliza el cultivo y la venta de marihuana con fines medicinales en 2015 que proporcionó marihuana medicinal gratuita a casi 4.000 pacientes. A principios de este año, el país inauguró la mayor granja de marihuana medicinal en América Latina. Además, la presidenta de Chile, Michelle Bachelet firmó un decreto para eliminar la marihuana de una lista de drogas peligrosas. El decreto también permite que la marihuana medicinal se venda en las farmacias, ofreciéndoles un mayor acceso a los pacientes.
Acerca de HempMeds ®
HempMeds® que creó el primer "canal de suministro de CBD" en los Estados Unidos, es una compañía de la cartera de empresas de Medical Marijuana, Inc. (OTC PINK: MJNA) y el principal distribuidor exclusivo y compañía de marketing por contrato de la Compañía. HempMeds ofrece legalmente al mercado estadounidense una amplia gama de productos de cannabis y CBD en los 50 estados.
Acerca de Medical Marijuana, Inc.
Nuestra misión es convertirnos en los principales innovadores en la industria de cannabis y cáñamo, aprovechando nuestro equipo de profesionales para buscar, evaluar y adquirir compañías y productos de valor agregado, a la vez que les permitimos mantener su integridad y su espíritu emprendedor. Nos esforzamos por crear conciencia dentro de nuestra industria, desarrollar negocios ecológicos y económicamente sostenibles y, a su vez, aumentar el valor para los accionistas. Para obtener más información acerca de la cartera y las compañías de inversión de Medical Marijuana, Inc., ingrese en www.medicalmarijuanainc.com.
Para ver la declaración en video de Medical Marijuana, Inc., haga clic aquí. Se recomienda a los accionistas que visiten también Medical Marijuana, Inc. Shop en cuanto a productos con descuento.
DESCARGO DE RESPONSABILIDAD SOBRE DECLARACIONES PROSPECTIVAS
Este comunicado de prensa puede contener ciertas declaraciones e información de carácter prospectivo, tal como se define en la sección 27A de la Ley de Valores de 1933 y la sección 21E de la Ley de Bolsas de Valores de 1934 y está sujeto a las disposiciones de puerto seguro establecidas por dichas secciones. Este material contiene declaraciones acerca de futuros eventos o resultados financieros esperados que son de naturaleza prospectiva y están sujetos a riesgos e incertidumbres. Tales declaraciones prospectivas por definición conllevan riesgos, incertidumbres y otros factores que pueden causar que los resultados reales, el rendimiento o los logros de Medical Marijuana, Inc. sean sustancialmente diferentes a las declaraciones emitidas en este comunicado.
DECLARACIÓN DE LA ADMINISTRACIÓN DE DROGAS Y ALIMENTOS (FDA)
Estas declaraciones no han sido evaluadas por la FDA y no tienen el propósito de diagnosticar, tratar ni curar ningún tipo de enfermedad.
DIVULGACIÓN LEGAL
Medical Marijuana Inc. no vende ni distribuye ningún producto que infrinja la Ley de Sustancias Controladas de los Estados Unidos (US.CSA). Estas compañías producen, venden y distribuyen productos con aceite de cáñamo y participan en la distribución legal a nivel federal de productos medicinales que contienen marihuana dentro de determinados mercados internacionales. El cannabidiol es un ingrediente natural del aceite de cáñamo.
Información de contacto
Contacto de Relaciones Públicas:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Contacto de Negocios Corporativos:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
Símbolo OTC: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Contacto de Relaciones con Inversores:
EquiNet, LLC
Línea gratuita: (877) 964.6463
Oficina/Directo: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc., subsidiária da HempMeds(R) anuncia criação de empresa no Chile, início de importação para a Argentina
Dec 15, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc., subsidiária da HempMeds(R) anuncia criação de empresa no Chile, início de importação para a Argentina
Empresa dá continuidade a suas iniciativas de expansão internacional com criação de empresa no Chile e início de importação do Real Scientific Hemp Oil(TM) para a Argentina
SAN DIEGO, CA--(Marketwired - 15 de dezembro de 2016) - A Medical Marijuana, Inc. (OTC PINK: MJNA), primeira empresa de cannabis comercializada publicamente nos Estados Unidos, anunciou hoje que a sua subsidiária HempMeds® criou uma nova empresa no Chile. Além disso, como parte da sua iniciativa de expansão no mercado da América Latina, a empresa deu início à importação do seu principal produto, Real Scientific Hemp Oil™ (RSHO™) para a Argentina.
Esta nova expansão para a América Latina dá seguimento à primeira aprovação federal do COFEPRIS para a importação de produto de cannabis no México, juntamente com duas outras aprovações históricas para a importação do RSHO™ para o Brasil e Paraguai.
"Estamos orgulhosos com a criação da nossa empresa no Chile e com a expansão da distribuição do HempMeds®RSHO™ para mais países na América Latina. Outros países da região, tais como Brasil, Paraguai e México, legalizaram os produtos CBD para tratamento de vários problemas médicos, por isso uma empresa no Chile e uma rede de distribuição para a Argentina foi o melhor direcionamento lógico para a empresa", disse o CEO da Medical Marijuana, Inc., Dr. Stuart Titus. "Estamos muito contentes com o novo empreendimento e esperamos poder ajudar na criação de novas oportunidades econômicas para as pessoas do Chile e da Argentina".
"Novas legislações, tal como a decisão da Argentina de autorizar a importação do óleo de cannabis, são um passo gigantesco em direção da nossa meta contínua de educar o mundo sobre as vantagens médicas em potencial que os canabióides podem proporcionar. O Chile será um dos nossos maiores mercados na América Latina devido a esses novos regulamentos e o plano do governo de pagar pelos produtos para a população no futuro", acrescentou o Dr. Titus.
O Chile teve muito avanço desde a aprovação de uma lei que legaliza o cultivo e a venda de marijuana para fins medicinais em 2015, que proporciona a quase 4.000 pacientes marijuana medicinal gratuitamente. No início do ano, o país inaugurou sua maior fazenda de marijuana medicinal da América Latina. A presidente do Chile, Michelle Bachelet assinou uma lei para a remoção da marijuana da lista de drogas perigosas. A medida também permite que a marijuana médica seja vendida nas farmácias, dando aos pacientes maior acesso.
HempMeds ®
A HempMeds®, que criou o primeiríssimo "pipeline de CBD" nos Estados Unidos, é uma empresa de portfólio corporativo da Medical Marijuana, Inc. (OTC PINK: MJNA), e é a distribuidora exclusiva da Empresa e empresa de marketing contratada. A HempMeds oferece uma ampla variedade de produtos de cannabis e de CBD legalmente nos 50 estados dos Estados Unidos.
Medical Marijuana Inc.
Temos por missão ser o principal inovador do mercado de cannabis e hemp, utilizando nossos profissionais para obter, avaliar e comprar empresas e produtos de valor agregado, mantendo sua integridade e espírito empresarial. Buscamos disseminar o conhecimento na nossa indústria, desenvolver empresas ambientalmente positivas e economicamente sustentáveis, e aumentar o valor dos acionistas. Para mais detalhes sobre as empresas do portfólio e de investimentos da Medical Marijuana, Inc., visite www.medicalmarijuanainc.com.
Para ver o vídeo com a declaração da Medical Marijuana, Inc., clique aqui. Os acionistas também devem visitar o site Medical Marijuana, Inc. Shop para ver a lista de produtos oferecidos com desconto.
DECLARAÇÕES DE PREVISÃO
Este press release pode conter certas declarações e informações de previsão, de acordo com o disposto na Seção 27A do Securities Act of 1933 e Seção 21E do Securities Exchange Act of 1934, sujeitas ao regulamento de Safe Harbor estabelecido por tais seções. Este material contém declarações sobre eventos e/ou resultados futuros esperados que são consideradas declarações de previsão sujeitas a riscos e incertezas. Tais declarações de previsão, por definição, envolvem riscos, incertezas e outros fatores, que podem fazer com que os resultados, desempenho ou conquistas reais da Medical Marijuana, Inc. sejam substancialmente diferentes dos resultados previstos.
DECLARAÇÃO DA FOOD AND DRUG ADMINISTRATION (FDA) DOS EUA
Estas declarações não foram analisadas pela FDA e não têm por objetivo diagnosticar, tratar ou curar nenhuma doença.
DECLARAÇÃO LEGAL
A Medical Marijuana Inc. não vende nem distribui nenhum produto que violem a lei United States Controlled Substances Act (US.CSA). Estas empresas cultivam, vendem e distribuem produtos de hemp e estão envolvidas na distribuir legal de produtos medicinais de marijuana para certos mercados internacionais. Cannabidiol é um ingrediente natural do hemp oil.
Informação de Contato
Contato de Relações Públicas:
Andrew Hard
CEO
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Contato Comercial:
Nicholas R. Massalas
Diretor de Desenvolvimento Comercial
Medical Marijuana, Inc.
Símbolo OTC: MJNA
Ligação Gratuita: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Contato de Relação com o Investidor:
EquiNet, LLC
Ligação Gratuita: (877) 964.6463
Escritório/Direto: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Subsidiary HempMeds(R) Announces Formation of Business Operations in Chile, Begins Importation Into Argentina
Dec 15, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Subsidiary HempMeds(R) Announces Formation of Business Operations in Chile, Begins Importation Into Argentina
Company Continues International Expansion Initiatives with Company Formation in Chile and Begins Importing Real Scientific Hemp Oil(TM) to Argentinian Market
SAN DIEGO, CA--(Marketwired - December 15, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary company HempMeds® has formed a new business in Chile. Additionally, as part of the company's Latin American market expansion initiative, the company has begun importing their flagship product Real Scientific Hemp Oil™ (RSHO™) to Argentina.
This new Latin American expansion comes after the company received the first-ever federal approval from COFEPRIS to import a cannabis product into Mexico, along with two other historic first-ever approvals to import RSHO™ into Brazil and Paraguay.
"We are proud to be building a business in Chile and expanding our distribution of HempMeds® RSHO™ into more countries in Latin America. Other countries in the region such as Brazil, Paraguay and Mexico have legalized CBD products for the treatment of multiple medical indications, so developing a business presence in Chile and a distribution network into Argentina seemed like the best logical direction," said Chief Executive Officer of Medical Marijuana, Inc., Dr. Stuart Titus. "We are excited about the new venture and look forward to helping develop new economic opportunities for the people of Chile and Argentina."
"New legislation, like the recent decision by Argentina to allow the importation of cannabis oil are a giant step in our ever-continuing goal of educating the world on the potential medical advantages cannabinoids can provide. We believe Chile will be one of our largest markets in Latin America due to these new regulations and the government's plan to pay for the products for citizens in the future" added Dr. Titus.
In Chile, there have been many developments since the approval of a measure legalizing the cultivation and sale of marijuana for medicinal purposes in 2015 that have provided nearly 4,000 patients with free medical marijuana. Earlier this year the country opened the largest medicinal marijuana farm in Latin America. Also, Chilean President Michelle Bachelet signed a measure to remove marijuana from a list of dangerous drugs. The measure also allows for medical marijuana to be sold in pharmacies, giving patients greater access.
About HempMeds®
HempMeds® which created the first-ever "CBD pipeline" into the United States, is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company's exclusive master distributor and contracted marketing company. HempMeds offers the US market a wide range of cannabis and CBD products legally across all 50 states.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc. Announces Excitement for Recent Mexico Cannabis Regulations Vote
Dec 14, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc. Announces Excitement for Recent Mexico Cannabis Regulations Vote
New Ruling Helps Move Mexico Closer to Cannabis Legalization in the Country
SAN DIEGO, CA--(Marketwired - December 14, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it commends the Mexican senate for voting in favor of extending regulations for certain cannabis products. With the new regulations, more people in need of cannabis and cannabidiol (CBD) for medical care will have more access to products, including our RSHO brand of products.
Medical Marijuana, Inc. subsidiary HempMeds® Mexico`s non-psychoactive, THC-free hemp-based CBD product Real Scientific Hemp Oil-X™ (RSHO-X™) was the first-ever federally approved CBD product in Mexico. Now with the new regulations, it's a goal for HempMeds® Mexico to bring all their RSHO products into the country to help more customers and provide options.
"These new regulations in Mexico will be a major step forward for the country once they pass the Mexico House of Representatives then signed fully into law. This will also represent a major accomplishment for the cannabis industry as a whole. We are very happy with the outcome and trend that the Mexican Senate put forward with this vote," stated Chief Executive Officer of Medical Marijuana, Inc., Dr. Stuart Titus. "Our Company has always supported access to all cannabinoids, as we recognize the potential medical advantages they can provide.
"We believe this new legislation in Mexico will increase access to additional cannabis-based products and we will continue encouraging further cannabis reforms by educating doctors and lawmakers on the benefits of cannabinoids -- then creating products that can safely and reliably provide our customers with the cannabinoids they seek," added Dr. Titus.
The new law approves the use of marijuana with therapeutic and medicinal use, with the reforms through General Health Law. This law will allow the access to cannabis based products to treat chronic and degenerative diseases. This law is yet to be approved by the House of Representative, which may be next year.
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at: http://www.hempmeds.mx.
About HempMeds®
HempMeds® which created the first-ever "CBD pipeline" into the United States, is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company's exclusive master distributor and contracted marketing company. HempMeds offers the US market a wide range of cannabis and CBD products legally across all 50 states.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana (MJNA) Capitalizes on the $450 Million CBD Market -- CFN Media
Dec 14, 2016
OTC Disclosure & News Service
-
Medical Marijuana (MJNA) Capitalizes on the $450 Million CBD Market -- CFN Media
SEATTLE, WA--(Marketwired - Dec 14, 2016) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.'s (OTC PINK: MJNA) global position in the burgeoning market for hemp-derived, cannabidiol (CBD)-based products.
According to the Hemp Industry Association, annual retail sales of hemp products grew at a 10.4% clip to surpass $570 million in 2015. Industrial applications still account for most of the market, but hemp foods, personal care products, supplements, and hemp-derived CBD products have experienced a growing market share. Hemp Business Journal's CBD Report projects that hemp-based CBD products will become a $450 million market by 2020.
Google Scholar has archived more than 2,000 research papers discussing CBD's role in the treatment of various medical conditions this year. With hemp-based CBDs widely available to researchers in the United States, a growing number of researchers have become interested in the cannabinoid's potential across a spectrum of diseases. These published papers could eventually sway the medical community and open the door to new therapeutics.
Medical Marijuana Inc. is building a global footprint in the CBD industry with its Real Scientific Hemp Oil ("RSHO"
- a hemp-derived pure CBD oil that's available over the counter - until the scientific community catches up. With distribution across all of the United States and numerous countries around the world including Mexico, Columbia, and Brazil, the company has become a leader in providing pure CBD oils that have been shown to be effective in treating epilepsy, pain, and other conditions. In addition to its over-the-counter products, the company has a 45.5% stake in AXIM Biotech Inc., which owns the patent for chewing gum as a delivery method for cannabinoids. The company will soon start Phase III clinical trials for their combination CBD/THC gum MedChew™ RX for the treatment of spasticity associated with multiple sclerosis and, once approved by the EMA, the gum will be offered across the European Union.
The company also holds a portfolio of other companies focused on distributing and marketing CBDs and advancing the science of cannabinoids. For example, its Kannaway subsidiary is focused on marketing cannabinoids throughout the United States with a variety of different products targeting areas like skincare, while its Kannalife subsidiary holds an exclusive license from the NIH for the commercialization of US Patent 6,630,507 for neuroprotection.
Follow the link to read the full article: http://www.cannabisfn.com/medical-marijuana-m...bd-market/
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id...1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit http://www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Forbes Features Medical Marijuana, Inc. in Article Citing Company's Sales Data After Starting CBD Market `That Could Grow 700% by 2020'
Dec 13, 2016
OTC Disclosure & News Service
-
Forbes Features Medical Marijuana, Inc. in Article Citing Company's Sales Data After Starting CBD Market `That Could Grow 700% by 2020'
Article Features Positive Growth Stats for the CBD Market and Information on Medical Marijuana, Inc. Products, Investments and Subsidiary Companies
SAN DIEGO, CA--(Marketwired - December 13, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its products and investments were featured in a Forbes article focused on the current cannabidiol (CBD) market size and anticipated massive growth.
The Dec. 12, 2016, article entitled "The Cannabis Market That Could Grow 700% by 2020" states, "The Hemp Business Journal estimated that the CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources." Those figures cited would total a 700% increase from 2016.
The article continues: "Medical Marijuana, Inc. said that there were $65 million in hemp-based CBD sales in 2015 and that they are the current market leader with over $800,000 in retail CBD sales per month. Their CBD sales have grown from $3.4 [million] in 2013 and are expected to be $9 million in 2016."
"When Medical Marijuana, Inc. launched the first-ever hemp-based CBD products, the Company knew that we were creating an intriguing product category that could potentially help millions of people to higher levels of overall health and wellness. We're grateful to Forbes for covering our industry," said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. "However, not everyone predicted a $65 million industry within two years and a projected $450 million industry within seven years. That has meant jobs and livelihood for thousands of people around the world."
"Further, the black market for cannabis (THC) products has been developing for the past 50 years and today reaches $120 billion in the US and $240 billion worldwide. We continue to believe that when similarly developed, the CBD marketplace will approach 50% of these figures, so $60 billion in the US and $120 billion worldwide."
The Forbes article also discusses many of Medical Marijuana, Inc.'s subsidiary companies including Kannaway and their line of Revive products like Revive Pro-X, a hemp oil supplement containing no tetrahydrocannabinol (THC), that is made for customers like athletes who need to avoid products with THC.
Further, the article also discussed Medical Marijuana, Inc. investment AXIM® Biotechnologies, Inc. (OTC: AXIM) and the patent received by the company for the CBD chewing gum CanChew®. Medical Marijuana, Inc. owns 47% of Axim stock.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About AXIM®
AXIM® Biotechnologies, Inc. (OTC: AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. We prioritize the well-being of our customers while embracing a solid fiscal strategy. Medical Marijuana, Inc. is a major investor in AXIM. For more information, visit www.AXIMBiotech.com.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Medical Marijuana, Inc.'s HempMeds(R) to Showcase Award-Winning Hemp Oil Cannabidiol (CBD) and Cannabis Beauty Defined Products at A4M World Congress
Dec 08, 2016
OTC Disclosure & News Service
-
Medical Marijuana, Inc.'s HempMeds(R) to Showcase Award-Winning Hemp Oil Cannabidiol (CBD) and Cannabis Beauty Defined Products at A4M World Congress
HempMeds(R) to Educate Thousands of Global Healthcare Professionals Attending the World Congress on Anti-Aging Medicine on Rapidly Emerging Hemp Cannabidiol (CBD) Industry
SAN DIEGO, CA--(Marketwired - December 08, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® is exhibiting at the 24th annual American Academy of Anti-Aging Medicine World Congress (A4M), with the Company's extensive portfolio of retail-ready cannabis products featured at the Venetian/Palazzo Hotel in Las Vegas from Dec. 9-11.
HempMeds® representatives will exhibit at booth #1027 the Company's groundbreaking Real Scientific Hemp Oil™ (RSHO™) including its hemp cannabidiol (CBD) oil raw ingredient and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™), the first-ever cannabis product to receive approval from the federal government of Mexico for importation. Additionally, the Company will be showcasing their award-winning range of Cannabis Beauty Defined™ products that are a unique mixture of CBD hemp oil and a specially formulated mixture of herbs to help protect and nourish the skin.
"We are very fortunate to have the opportunity to attend another A4M Conference and to be able to bring our products to the forefront of this market," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We are proud that our products will be showcased to thousands of the premier anti-aging doctors and experts from around the world. The Company's goal is to educate and open up a worldwide conversation on CBD from the hemp plant."
The A4M Conference is dedicated to the advancement of technology to detect, prevent, and treat aging-related disease and to promote research into methods to optimize the human aging process. Patent No. 6630507, awarded to the U.S. Department of Health and Human Services, states that cannabinoids have been found to have antioxidant and anti-aging properties.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
Image Available: http://www.marketwire.com/library/MwGo/2016/1...9b117e.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/1...c6332a.jpg
Contact information
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
(0)
(0)Scroll down for more posts ▼